Navigating the Complexity of the GI Microbiome in Clinical Practice

Throughout the heavy research process during the development of the GI EcologiX, there were many discoveries which we will share with you throughout this free webinar.


When
28th January 2020
6:30 pm GMT

Description


At Invivo we pride ourselves in translating the wealth of complex information around the GI microbiome into clinical relevance. Patient outcomes govern what we do and with this in mind, we created a new GI profile called GI EcologiX™.

Throughout the heavy research process during development, there were many discoveries which we will share with you throughout this webinar, which we are running in collaboration with IHCAN.

Learning Objectives
  • How to use ‘systems theory’ thinking to view the human microbiome as a dynamic and contextually-rich ecosystem.
  • The importance of the GI immune system – including inflammation and antimicrobial peptides in health and disease.
  • Understand the role of ‘syntrophy’ in short-chain fatty acid (SCFA) production by commensal bacteria.
  • Learn more about the importance of Bacteroides species – the good, the bad and the ugly.
  • Understand the different roles of key Ruminococcus species in health and disease.
  • Learn about novel microbes and mycology involvement as triggers for inflammatory pathways and IBD in the GI tract.
  • The importance of molecular methodologies and endogenous gene controls in mapping the human microbiome.
  • Learn about the new comprehensive GI EcologiX™ microbiome profile from Phylo Bioscience™, a CQC registered UK microbiome laboratory.

Speakers


  • Humphrey Bacchus

    Humphrey Bacchus is the MD at Invivo Healthcare, and founder of the UK-based microbiology lab, Phylo Bioscience. His vision for the laboratory was to develop multiple host-microbiome clinical diagnostics for healthcare professionals. His research interests focus on the microbiome-immune interface and its role in health and disease. Under his guidance, Phylo Bioscience has commercially developed and brought to market microbiome profiles assessing the gastrointestinal, oral and vaginal ecosystems, whilst also conducting research work into the oral-gut microbiome and the pathogenesis of neurodegenerative disorders.

Related Articles


Bio.Me, Bio.Me Barrier, Gastrointestinal
Looking for a product to support gut barrier function?

When is barrier function a relevant clinical consideration? The importance of an effective physical and immune barrier at the site of host-microbiome interactions cannot be downplayed. Our solution is Bio....

Diagnostics, Gastrointestinal, GI EcologiX™
Changes to our Gastrointestinal Microbiome Offerings

On behalf of Invivo Healthcare, I’d like to address a recent change to our gastrointestinal microbiome offerings. Invivo no longer sell the GI-MAP, we now only offer GI EcologiX ...

Bio.Clear, Gastrointestinal, Microbiome
New Bio.Clear™ Microbia GI

Our new anti-microbial botanical blend for dysbiotic microbiome(s)